HK1061026A1 - 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds - Google Patents

3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds

Info

Publication number
HK1061026A1
HK1061026A1 HK04104077A HK04104077A HK1061026A1 HK 1061026 A1 HK1061026 A1 HK 1061026A1 HK 04104077 A HK04104077 A HK 04104077A HK 04104077 A HK04104077 A HK 04104077A HK 1061026 A1 HK1061026 A1 HK 1061026A1
Authority
HK
Hong Kong
Prior art keywords
antiarhythmic
diazabicyclo
formulations
compounds
antiarhythmic compounds
Prior art date
Application number
HK04104077A
Other languages
English (en)
Inventor
Neil Barnwell
Annika Bjoer
Lal Cheema
David Cladingboel
Adam Herring
Karin Lovqvist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1061026A1 publication Critical patent/HK1061026A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK04104077A 2001-04-12 2004-06-08 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds HK1061026A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101327A SE0101327D0 (sv) 2001-04-12 2001-04-12 New crystalline forms
PCT/SE2002/000725 WO2002083688A1 (en) 2001-04-12 2002-04-12 3,7-diazabicyclo [3.3.1] formulations as antiarhythmic compounds

Publications (1)

Publication Number Publication Date
HK1061026A1 true HK1061026A1 (en) 2004-09-03

Family

ID=20283783

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04104077A HK1061026A1 (en) 2001-04-12 2004-06-08 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds

Country Status (30)

Country Link
US (1) US7217708B2 (et)
EP (2) EP1550663A1 (et)
JP (1) JP2004525970A (et)
KR (1) KR20030087078A (et)
CN (1) CN1269823C (et)
AR (1) AR035452A1 (et)
AT (1) ATE323095T1 (et)
BR (1) BR0208829A (et)
CA (1) CA2443470A1 (et)
CZ (1) CZ20032760A3 (et)
DE (1) DE60210598T2 (et)
DK (1) DK1389213T3 (et)
EE (1) EE200300504A (et)
ES (1) ES2261721T3 (et)
HK (1) HK1061026A1 (et)
HU (1) HUP0303487A3 (et)
IL (1) IL158250A0 (et)
IS (1) IS6980A (et)
MX (1) MXPA03009206A (et)
NO (1) NO20034527L (et)
NZ (1) NZ528560A (et)
PL (1) PL367179A1 (et)
PT (1) PT1389213E (et)
RU (1) RU2286993C2 (et)
SE (1) SE0101327D0 (et)
SK (1) SK12572003A3 (et)
TW (1) TWI237025B (et)
UA (1) UA74629C2 (et)
WO (1) WO2002083688A1 (et)
ZA (1) ZA200307759B (et)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI259836B (en) * 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
AU2006258293B2 (en) * 2005-06-13 2010-06-17 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
AR053901A1 (es) * 2005-06-20 2007-05-23 Astrazeneca Ab Formas fisicas de oxabispidinas n,n'- disustituidas
KR20080028435A (ko) * 2005-06-20 2008-03-31 아스트라제네카 아베 N,n’-이치환된 옥사비스피딘의 제조 방법
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
WO2007103970A2 (en) * 2006-03-07 2007-09-13 Endacea, Inc. Compositions and methods for treating respiratory disorders
DK3357911T3 (da) 2006-06-26 2022-07-04 Akebia Therapeutics Inc Prolylhydroxylaseinhibitorer og fremgangsmåder til anvendelse
NO2686520T3 (et) 2011-06-06 2018-03-17
US20120329836A1 (en) 2011-06-06 2012-12-27 The Ohio State University Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
US11857543B2 (en) 2013-06-13 2024-01-02 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
CR20200220A (es) 2013-11-15 2020-11-18 Akebia Therapeutics Inc FORMAS SÓLIDAS DE ÁCIDO {[5-(3-CLOROFENIL)-3-HIDROXIPIRIDIN-2-CARBONIL]AMINO}ACÉTICO, COMPOSICIONES, Y USOS DE LAS MISMAS (Divisional 2016-0222)
JP2018502882A (ja) 2015-01-23 2018-02-01 アケビア セラピューティクス インコーポレイテッドAkebia Therapeutics Inc. 2−(5−(3−フルオロフェニル)−3−ヒドロキシピコリンアミド)酢酸の固体形態、その組成物及び使用
MX2017012460A (es) 2015-04-01 2018-01-30 Akebia Therapeutics Inc Composiciones y metodos para el tratamiento de la anemia.
TWI822776B (zh) 2018-05-09 2023-11-21 美商阿克比治療有限公司 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9902268D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds

Also Published As

Publication number Publication date
IL158250A0 (en) 2004-05-12
JP2004525970A (ja) 2004-08-26
EP1389213B1 (en) 2006-04-12
CA2443470A1 (en) 2002-10-24
TWI237025B (en) 2005-08-01
DK1389213T3 (da) 2006-07-10
PL367179A1 (en) 2005-02-21
RU2286993C2 (ru) 2006-11-10
ATE323095T1 (de) 2006-04-15
KR20030087078A (ko) 2003-11-12
EE200300504A (et) 2003-12-15
CN1269823C (zh) 2006-08-16
ES2261721T3 (es) 2006-11-16
NZ528560A (en) 2005-05-27
ZA200307759B (en) 2005-01-03
CN1514837A (zh) 2004-07-21
EP1389213A1 (en) 2004-02-18
NO20034527L (no) 2003-12-10
NO20034527D0 (no) 2003-10-09
MXPA03009206A (es) 2004-01-29
BR0208829A (pt) 2004-03-09
PT1389213E (pt) 2006-07-31
AR035452A1 (es) 2004-05-26
US20040143000A1 (en) 2004-07-22
HUP0303487A3 (en) 2005-04-28
HUP0303487A2 (hu) 2004-01-28
RU2003129231A (ru) 2005-04-10
WO2002083688A1 (en) 2002-10-24
CZ20032760A3 (cs) 2004-01-14
IS6980A (is) 2003-10-08
DE60210598D1 (de) 2006-05-24
DE60210598T2 (de) 2007-02-08
US7217708B2 (en) 2007-05-15
EP1550663A1 (en) 2005-07-06
UA74629C2 (en) 2006-01-16
SE0101327D0 (sv) 2001-04-12
SK12572003A3 (sk) 2004-07-07

Similar Documents

Publication Publication Date Title
MXPA03008275A (es) Formulas antibacteriales.
MXPA03009558A (es) Compuestos novedosos.
HK1051193A1 (en) (1,4')-Bipiperidine compounds.
MXPA03007093A (es) Nueva composicion.
MXPA03008961A (es) Composicion de vacuna.
AP2002002695A0 (en) Pyrrolo Ä2,3-dÜpyrimidine compounds
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
MXPA03009361A (es) Compuestos de urea utilies como agentes anti-inflamatorios.
HK1061026A1 (en) 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds
MXPA03009698A (es) Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph.
ZA200302929B (en) Compositions comprising cyclohexamantane.
MXPA03007693A (es) Composicion para la piel.
ZA200206779B (en) Solid formulation.
EG23378A (en) Composition.
MXPA03002117A (es) Composiciones fungicidas.
MXPA03001263A (es) Formulacion fungicida.
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
IL158033A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds
ZA200403323B (en) Anthelmintic composition.
IL158035A0 (en) 3, 7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds
MXPA03008077A (es) Composicion humedecedora para la piel..
ZA200110500B (en) Pharmaceutical composition.
SI1389213T1 (sl) 3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
MXPA03007318A (es) Composicion farmaceutica.
SI1497256T1 (sl) Substituirane 1,5-diaminopentan-3-olne spojine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100412